Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cells
- 1 November 2008
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 82 (21) , 10502-10509
- https://doi.org/10.1128/jvi.00970-08
Abstract
H5N1 influenza A viruses are exacting a growing human toll, with more than 240 fatal cases to date. In the event of an influenza pandemic caused by these viruses, embryonated chicken eggs, which are the approved substrate for human inactivated-vaccine production, will likely be in short supply because chickens will be killed by these viruses or culled to limit the worldwide spread of the infection. The Madin-Darby canine kidney (MDCK) cell line is a promising alternative candidate substrate because it supports efficient growth of influenza viruses compared to other cell lines. Here, we addressed the molecular determinants for growth of an H5N1 vaccine seed virus in MDCK cells, revealing the critical responsibility of the Tyr residue at position 360 of PB2, the considerable requirement for functional balance between hemagglutinin (HA) and neuraminidase (NA), and the partial responsibility of the Glu residue at position 55 of NS1. Based on these findings, we produced a PR8/H5N1 reassortant, optimized for this cell line, that derives all of its genes for its internal proteins from the PR8(UW) strain except for the NS gene, which derives from the PR8(Cambridge) strain; its N1 NA gene, which has a long stalk and derives from an early H5N1 strain; and its HA gene, which has an avirulent-type cleavage site sequence and is derived from a circulating H5N1 virus. Our findings demonstrate the importance and feasibility of a cell culture-based approach to producing seed viruses for inactivated H5N1 vaccines that grow robustly and in a timely, cost-efficient manner as an alternative to egg-based vaccine production.Keywords
This publication has 41 references indexed in Scilit:
- Establishment of Canine RNA Polymerase I-Driven Reverse Genetics for Influenza A Virus: Its Application for H5N1 Vaccine ProductionJournal of Virology, 2008
- Enhanced growth of seed viruses for H5N1 influenza vaccinesVirology, 2007
- Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed HumansPLoS Medicine, 2007
- Contributions of Two Nuclear Localization Signals of Influenza A Virus Nucleoprotein to Viral ReplicationJournal of Virology, 2007
- Flu-vaccine makers toil to boost supplyNature, 2006
- The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolateVaccine, 2006
- Molecular Basis of Replication of Duck H5N1 Influenza Viruses in a Mammalian Mouse ModelJournal of Virology, 2005
- Improvement of Influenza A/Fujian/411/02 (H3N2) Virus Growth in Embryonated Chicken Eggs by Balancing the Hemagglutinin and Neuraminidase Activities, Using Reverse GeneticsJournal of Virology, 2005
- Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virusNature, 2004
- From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenzaNature Reviews Microbiology, 2004